EcoDrugPlus

G-Protein Coupled Receptor 84-Like

Ensembl ID : ENSACLG00000000031
Gene Symbol: LOC113021710
3 Cross references
114 Possible Orthologues:

Gtpase Kras

Ensembl ID : ENSACLG00000027515
Gene Symbol: LOC113026977
3 Cross references
209 Possible Orthologues:

Hck Proto-Oncogene, Src Family Tyrosine Kinase

Ensembl ID : ENSACLG00000006685
Gene Symbol: HCK
3 Cross references
203 Possible Orthologues:

Il2 Inducible T Cell Kinase

Ensembl ID : ENSACLG00000000656
Gene Symbol: ITK
3 Cross references
208 Possible Orthologues:

Janus Kinase 1

Ensembl ID : ENSACLG00000001880
Gene Symbol: JAK1
3 Cross references
214 Possible Orthologues:

Mapk Activated Protein Kinase 2

Ensembl ID : ENSACLG00000005513
Gene Symbol: MAPKAPK2
3 Cross references
186 Possible Orthologues:

Mapk Activated Protein Kinase 5

Ensembl ID : ENSACLG00000013404
Gene Symbol: MAPKAPK5
3 Cross references
179 Possible Orthologues:

Mapk Interacting Serine/threonine Kinase 2

Ensembl ID : ENSACLG00000011252
Gene Symbol: MKNK2
3 Cross references
208 Possible Orthologues:

Mcl1 Apoptosis Regulator, Bcl2 Family Member B

Ensembl ID : ENSACLG00000004468
Gene Symbol: MCL1B
1 Cross references
212 Possible Orthologues:

Mdm2 Proto-Oncogene

Ensembl ID : ENSACLG00000012579
Gene Symbol: MDM2
3 Cross references
280 Possible Orthologues:

Met Proto-Oncogene, Receptor Tyrosine Kinase

Ensembl ID : ENSACLG00000012614
Gene Symbol: MET
3 Cross references
204 Possible Orthologues:

Mtor Associated Protein, Lst8 Homolog

Ensembl ID : ENSACLG00000016240
Gene Symbol: MLST8
3 Cross references
195 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).